prostate cancer Archives

GermanyPredicting potent drug combinations by exploiting monotherapy resistance

July 19, 2022by pcdata0

Dates: 01/01/2021 31/12/2025 Topic: Biomarkers identification AI/Big data Project type: Preclinic Theranostic Project target: Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: Prostate cancer; colorectal cancer; drug resistance; reinforcement; tumour; biomarker; HTS; QSAR; monotherapy Countries: Germany Project page: Access...

Italy Netherlands SpainA novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids

July 19, 2022by pcdata0

Dates: 01/01/2021 31/12/2024 Topic: Tool Project type: Preclinic Theranostic Project target: Prostate Cancer Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge Participating agents: DESTINA GENOMICA SLNE OPTOELETTRONICA ITALIA SRL UNIVERSITA DEGLI STUDI DI CATANIA UNIVERSITA DEGLI STUDI DI TRENTO PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE...

GermanyPredicting potent drug combinations by exploiting monotherapy resistance

July 19, 2022by pcdata0

Dates: 01/01/2021 31/12/2025 Topic: Biomarkers identification Project type: Preclinic Theranostic Project target: Prostate Cancer Colorectal Cancer Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Keywords: reinforcement; drug resistance; colorectal cancer; prostate cancer; oncology; monotherapy; HTS Countries: Germany Project page: Access page...